Blog Post by Admin
Publication
Feb 14, 2023
Fournier's gangrene in patients with type 2 diabetes using second‐line antidiabetic medications
Cases of a rare but serious infection called Fournier's gangrene have been reported with ...
Start Reading
Publication
Feb 14, 2023
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients
Background The COVID-19 pandemic remains a significant global threat. However, despite ...
Start Reading
Publication
Feb 14, 2023
Chronic opioid use and complication risks in women with endometriosis: a cohort study in US administrative claims
Background Women with endometriosis are prescribed opioids for pain relief but may be ...
Start Reading
Publication
Feb 14, 2023
Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study
Objective To compare real-world effectiveness and safety of direct oral anticoagulants ...
Start Reading
Publication
Feb 14, 2023
Availability of comparative real-world evidence research in Medicare patients: Implications for CMS drug price negotiations
To evaluate the availability of published comparative real-world evidence (RWE) studies ...
Start Reading
Publication
Feb 14, 2023
Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase
While serious liver injury among statin users is extremely rare, baseline liver enzyme ...
Start Reading
Publication
Feb 14, 2023
Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use
Introduction The Premier Perspective hospital billing database provides a promising data ...
Start Reading
Publication
Feb 14, 2023
Empirical assessment of case‐based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project
Objectives To introduce the methodology of the ALCAPONE project. Background The French ...
Start Reading
Publication
Feb 14, 2023
Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study
Introduction: CKD, a common complication of type-2 diabetes (T2D), causes considerable ...
Start Reading
Publication
Feb 14, 2023
Real‐world evidence on bariatric surgery and cardiovascular benefits using electronic health record data: A lesson in bias
Aim To reproduce and correct studies on bariatric surgery and the reduction in major ...
Start Reading
Publication
Feb 14, 2023
Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: a nationwide US study
No abstract available
Start Reading
Publication
Feb 14, 2023
Transparency and reproducibility of observational cohort studies using large healthcare databases.
The scientific community and decision-makers are increasingly concerned about ...
Start Reading
Publication
Feb 14, 2023
Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the US: A retrospective analysis of claims data
No Link
Start Reading
Publication
Feb 14, 2023
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting
Transparency is increasingly promoted to instill trust in nonrandomized studies using ...
Start Reading
Publication
Feb 14, 2023
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge
Importance Vaccination against the SARS-CoV-2 virus is critical to control the pandemic. ...
Start Reading
Publication
Feb 14, 2023
Empirical assessment of case‐based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS)
Purposes Drug induced acute liver injury (ALI) is a frequent cause of liver failure. ...
Start Reading
Publication
Feb 14, 2023
Post-Authorization Safety Studies of Medicinal Products: The PASS, Chapter 3.4 Big Data
Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in ...
Start Reading
Publication
Feb 14, 2023
Association of remdesivir with lower mortality in hospitalized adults with Covid-19 in the United States
Importance SARS-CoV-2, which causes COVID-19, poses considerable morbidity and mortality ...
Start Reading
Publication
Feb 14, 2023
Opioid dispensing patterns after oocyte retrieval
Objective: To study opioid dispensing patterns following oocyte retrieval. Design: ...
Start Reading
Publication
Feb 14, 2023
Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014
Aim To compare the incidence of lower extremity amputation (LEA) among patients with type ...
Start Reading
Publication
Feb 14, 2023
Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study.
Study Objectives Narcolepsy is associated with cardiovascular risk factors; however, the ...
Start Reading
Publication
Feb 14, 2023
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Importance Understanding the effect of serum antibodies to severe acute respiratory ...
Start Reading
Publication
Feb 14, 2023
Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
Background Chronic kidney disease (CKD), one of the most common complications of type 2 ...
Start Reading
Publication
Feb 14, 2023
Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US
Objectives There is lack of clarity regarding the role of angiotensin receptor blockers ...
Start Reading